The Estee Lauder Companies Inc. (EL)

NYSE: EL · USD

$109

+0.86 (+0.8%)· Recorded snapshot

StockMarketAgent Research · Analyzed 2026-10-03

Our latest published analysis: EL rated Sell

The Estee Lauder Companies Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$51.6 / share

Potential value

$69.2 / share

Upside to FV

-43.9%

from $109

Moat

7.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$33.3B
Revenue (ttm)	15B
Net income (ttm)	182M
EPS (ttm)	$0.50
Shares out	361.8M
P/E (trailing)	218.4x
P/E (forward)	29.8x
Dividend	$1.40 (1.28%)
Volume	2,423,779
Beta	1.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15B
Net income (ttm): 182M
EPS (ttm): $0.50
P/E (trailing): 218.4x
P/E (forward): 29.8x
Market cap: $33.3B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30	Trend
Revenue	$17.74B	$15.91B	$15.61B	$14.33B	$15.05B	-4.0%
Gross profit	$13.43B	$11.35B	$11.18B	$10.60B	$11.36B	-4.1%
Operating income	$3.17B	$1.51B	$970.0M	$-785.0M	$780.0M	-29.6%
Net income	$2.39B	$1.01B	$390.0M	$-1.13B	$182.0M	-47.5%
EPS (diluted)	$6.55	$2.79	$1.08	$-3.15	$0.50	-47.4%
EBITDA	$3.93B	$2.40B	$1.98B	$146.0M	$1.65B	-19.5%
R&D	$307.0M	$344.0M	$360.0M	$316.0M	—	+1.0%
SG&A	$9.89B	$9.58B	$9.62B	$9.46B	$9.69B	-0.5%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sell
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Reduce
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Hold
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Reduce
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Buy
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Strong Buy

Base and Bull scenarios

Base55%

Price target

$51.63

-43.9% from spot

The modal expected path reflects gradual operational recovery under the Profit Recovery and Growth Plan, with FY2027 net sales growing 4.46% to $15,720M and FY2028 revenue expanding 4.28% to $16,393M. Operating margin normalizes from 5.18% in FY2026 to 9.20% in FY2027 and reaches 13.50% at the forecast horizon. Diluted EPS expands from trough GAAP $0.50 to $3.32 in FY2027 and $3.91 in FY2028. Discounted at an 8.46% WACC and 9.81% cost of equity, the fundamental composite fair value resolves to Fair value $51.63.

Net sales and revenue grow steadily across FY2027 and FY2028 as wholesale and retail channels normalize.
Operating margin normalizes sequentially from FY2026 trough levels toward long-term targets across the forecast horizon.
Diluted EPS expands across FY2027 and FY2028 supported by cost discipline and operational turnaround execution.

Bull20%

Price target

$69.17

-24.8% from spot

Upside optionality materializes if Hainan and Asian travel retail channels restock faster than expected, accelerating China revenue above historical baseline trends while M·A·C and prestige skincare drive mid-single-digit growth in the US. In this scenario, fixed SG&A leverage accelerates operating margin expansion by FY2028, pushing diluted EPS toward the high end of consensus ($4.30) and generating robust annual free cash flow, supporting valuation toward Potential value $69.17.

Revenue growth accelerates significantly supported by rapid restocking across Hainan and travel retail channels.
Operating margin expands beyond historical levels by FY2028 driven by aggressive overhead and SG&A expense reduction.
Diluted EPS reaches the upper end of sell-side consensus estimates by FY2028.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($51.63). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
8.8%	$55.8	$57.0	$58.2	$59.6	$61.1
9.3%	$52.7	$53.7	$54.7	$55.8	$57.0
9.8%	$50.0	$50.8	$51.6	$52.6	$53.6
10.3%	$47.5	$48.2	$48.9	$49.7	$50.6
10.8%	$45.4	$45.9	$46.6	$47.2	$48.0

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E29.8

P25 n/aP50 n/aP75 n/a

Trailing P/E183.9

P25 n/aP50 n/aP75 n/a

ROE4.7

P25 n/aP50 n/aP75 n/a

ROIC5.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EL indicators

Market & fundamental data

Available fields

283

Groups with data

Currency

USD

Showing 283 of 283 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001001250
Company name	The Estée Lauder Companies Inc.
Country	United States
Country code	US
CUSIP number	518439104
Earnings date	2026-11-02
Earnings time	bmo
Employees	55,000
Employees change	-2,000
Employees growth	-3.51%
Enterprise value	$45.3B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	1946
In index	SP500
Industry	Household & Personal Products
IPO date	1995-11-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US5184391044
Last 10-K release date	2026-08-19
Last earnings date	2026-08-19
Last refreshed	2026-10-28
Last stock split date	2012-01-23
Last stock split type	Forward
Market cap	$39.5B
Market cap category	Large-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$109.21
Price currency	USD
Sector	Consumer Staples
SIC code	2844
Stock price date	2026-10-28
Symbol	EL
U.S. state	New York
Website	https://www.elcompanies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	43.51x
Average P/E ratio (10Y)	61.92x
Average P/E ratio (5Y)	79.46x
Earnings yield	0.46%
EV/Earnings	248.56x
EV/EBIT	27.27x
EV/EBITDA	18.43x
EV/FCF	34.38x
EV/Sales	3.01x
FCF / EV yield	2.91%
FCF yield	3.33%
Forward EV/Sales	2.87x
Forward P/E	32.87x
Forward P/S	2.51x
Graham number	10.87871
Graham upside	-90.03%
Industry forward P/E	20.32x
Industry P/E	23.22x
Lynch fair value	$2.50
Lynch upside	-97.71%
P/(FCF - SBC) ratio	39.25x
P/(OCF - SBC) ratio	26.99x
P/B ratio	10.3x
P/E ratio	218.42x
P/FCF ratio	30.01x
P/OCF ratio	22.27x
P/S ratio	2.62x
PEG ratio	1.35x
Price/EBITDA ratio	16.09x
Sector forward P/E	21.3x
Sector P/E	28.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.02%
EBITDA margin	16.31%
Effective tax rate	64.8%
FCF margin	8.74%
Gross margin	75.49%
Operating margin	11.02%
Pretax margin	3.44%
Profit margin	1.21%
Profit per employee	$3,309
Profitable years	1
Revenue per employee	$273,618
ROA	5.23%
ROA (5Y)	5.69%
ROCE	12.26%
ROE	4.75%
ROE (5Y)	7.75%
ROIC	5.92%
ROIC (5Y)	12.48%
SBC / revenue	2.06%
Tax / revenue	2.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth 10Y	-16.29%
EPS growth 3Y	-43.62%
EPS growth 5Y	-42.26%
EPS growth quarters	1
EPS growth years	1
FCF growth	96.42%
FCF growth (Q)	7.87%
FCF growth (QoQ)	37.1%
FCF growth 3Y	21.82%
FCF growth 5Y	-15.16%
Gross profit growth	7.11%
Gross profit growth (Q)	11.24%
Gross profit growth 3Y	0.03%
Gross profit growth 5Y	-1.71%
Net income growth 3Y	-43.44%
Net income growth 5Y	-42.4%
Net income growth quarters	1
Net income growth years	1
OCF growth	39.39%
OCF growth (Q)	-4.16%
OCF growth (QoQ)	39.81%
OCF growth 10Y	-0.09%
OCF growth 3Y	0.8%
OCF growth 5Y	-13.36%
Operating income growth	45.4%
Operating income growth (Q)	72.79%
Operating income growth 3Y	-2.43%
Operating income growth 5Y	-11.23%
Revenue growth	5.05%
Revenue growth (Q)	6.33%
Revenue growth (QoQ)	-2.29%
Revenue growth 10Y	2.94%
Revenue growth 3Y	-1.84%
Revenue growth 5Y	-1.48%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-457M
Depreciation and amortization	$796M
EBIT	$1.7B
EBITDA	$2.5B
EPS	$0.50
FCF per share	$3.64
Financing cash flow	$-712M
Free cash flow	$1.3B
Free cash flow minus SBC	$1B
Gross profit	$11.4B
Income taxes	$335M
Investing cash flow	$-489M
Net borrowing	$-3M
Net cash flow	$577M
Net income	$182M
Operating cash flow minus SBC	$1.5B
Operating income	$1.7B
Revenue	$15B
Stock-based compensation	$310M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.18
Book value per share	$10.52
Debt / EBITDA	2.85
Debt / equity	2.43
Debt / FCF	7.03
Goodwill	$2.1B
Interest coverage	4.97
Long-term assets	$12.2B
Long-term liabilities	$9.7B
Net cash (debt)	$-5.7B
Net cash / market cap	-14.56%
Net debt / EBITDA	2.34
Net debt / equity	1.51
Net debt / FCF	4.37
Piotroski F-Score	7
Property, plant and equipment	$4.5B
Shareholders' equity	$3.8B
Tangible book value	$-1.9B
Tangible book value per share	$-5.20
Total assets	$19.8B
Total cash	$3.5B
Total debt	$9.2B
Total liabilities	$16B
WACC	9.33%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.76
Current assets	$7.6B
Current liabilities	$6.2B
Current ratio	1.22
Inventory turnover	1.81
Net working capital	$-1.2B
Quick ratio	0.81
Working capital	$1.4B
Working capital turnover	9.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.31%
Dividend growth	0%
Dividend growth (10Y)	1.55%
Dividend growth (3Y)	-19.06%
Dividend growth (5Y)	-7.96%
Dividend growth years	0
Dividend payment date	2026-09-15
Dividend payment years	31
Dividend payout frequency	Quarterly
Dividend per share	$1.40
Dividend yield	1.28%
Ex-dividend date	2026-08-31
FCF payout ratio	38.49%
Last dividend	$0.35
Payout ratio	280%
Shareholder yield	-0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	26.93%
10Y return CAGR	3.74%
10Y total return	44.3%
150-day SMA	$87.58
15Y price change	113.55%
15Y return CAGR	6.56%
15Y total return	159.43%
1D price change	0.79%
1M price change	15.44%
1M total return	15.44%
1W price change	2.77%
1W total return	2.77%
1Y price change	8.56%
1Y return CAGR	10.11%
1Y total return	10.11%
20-day SMA	$101.35
200-day SMA	$91.64
20Y price change	445.3%
20Y return CAGR	10.28%
20Y total return	608.15%
3M price change	31.08%
3M total return	31.53%
3Y price change	-12.42%
3Y return CAGR	-2.55%
3Y total return	-7.46%
50-day SMA	$99.89
50-day SMA vs 200-day SMA	50over200
52-week high	$121.64
52-week high date	2026-02-03
52-week low	$66.22
52-week low date	2026-04-02
5Y price change	-66.48%
5Y return CAGR	-18.39%
5Y total return	-63.8%
6M price change	41.05%
6M total return	42.08%
All-time high	$374.20
All-time high date	2022-01-03
All-time low	$7.94
All-time low date	1995-11-21
Average true range (ATR)	$3.33
Average volume	2.9M
Beta (1Y)	1.67
Beta (2Y)	1.55
Beta (5Y)	1.27
Change from 52-week high	-10.21%
Change from 52-week low	64.92%
Change from all-time high	-70.86%
Change from all-time low	1,273.9%
Change from open	1.23%
Day's gap	-0.43%
Dollar volume	$264.7M
High price	$110.01
Low price	$107.88
Monthly RSI	52.41
Open price	$107.88
Position in 52-week range	62.44%
Premarket change	-0.81%
Premarket close	$108.35
Premarket price	$107.47
Previous close	$108.35
Price vs 150-day SMA	24.52%
Price vs 20-day SMA	7.61%
Price vs 200-day SMA	19.01%
Price vs 50-day SMA	9.19%
Relative volume	0.85
RSI	66.62
Sharpe ratio	0.36
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	-0.29
Sortino ratio	0.62
Sortino ratio (3Y)	0.18
Sortino ratio (5Y)	-0.27
Volume	2.4M
Weekly RSI	62.59
YTD price change	4.14%
YTD total return	5.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	246.3M
Float percentage	68.08%
Shares change (QoQ)	-0.63%
Shares change (YoY)	1.31%
Shares held by insiders	11.3%
Shares held by institutions	65.34%
Shares outstanding	361.8M
Short % of float	2.71%
Short % of shares	1.84%
Short ratio	2.2 days

Deeper analysis on EL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this EL report

What is the latest published EL stock rating?

The Estee Lauder Companies Inc. is shown with Sell in the latest published report, analyzed 2026-10-03. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EL analysis?

The full latest published report, analyzed 2026-10-03, lives at /stocks/EL/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for EL?

The latest published report analyzed 2026-10-03 gives EL a fair value of USD 52 and a potential value of USD 69. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the EL page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-03). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

SellEL · Fair value $51.6-43.9%

Read full analysis →

The Estee Lauder Companies Inc. (EL)

Our latest published analysis: EL rated Sell

Price

Financial snapshot

Fair-value bridge

Latest news · EL

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All EL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EL

Frequently asked questions

Rating history

Category	Score	Reading
Valuation	1.5
Management	7.5
Balance Sheet	3.5
Profitability	3.5
Revenue Growth	6.0
Risk Assessment	4.0
Competitive Moat	7.5
Earnings Quality	6.0
Capital Efficiency	3.5